Exact Mass: 313.0845

Exact Mass Matches: 313.0845

Found 82 metabolites which its exact mass value is equals to given mass value 313.0845, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Hexaconazole

Pesticide6_Hexaconazole_C14H17Cl2N3O_2-(2,4-Dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2-hexanol

C14H17Cl2N3O (313.0749)


CONFIDENCE standard compound; INTERNAL_ID 1269; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9950; ORIGINAL_PRECURSOR_SCAN_NO 9948 CONFIDENCE standard compound; INTERNAL_ID 1269; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9938; ORIGINAL_PRECURSOR_SCAN_NO 9937 CONFIDENCE standard compound; INTERNAL_ID 1269; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9900; ORIGINAL_PRECURSOR_SCAN_NO 9899 CONFIDENCE standard compound; INTERNAL_ID 1269; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9947; ORIGINAL_PRECURSOR_SCAN_NO 9942 CONFIDENCE standard compound; INTERNAL_ID 1269; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9912; ORIGINAL_PRECURSOR_SCAN_NO 9911 CONFIDENCE standard compound; INTERNAL_ID 1269; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9988; ORIGINAL_PRECURSOR_SCAN_NO 9986

   

Flunitrazepam

5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one

C16H12FN3O3 (313.0863)


A benzodiazepine with pharmacologic actions similar to those of diazepam that can cause anterograde amnesia. Some reports indicate that it is used as a date rape drug and suggest that it may precipitate violent behavior. The United States Government has banned the importation of this drug. [PubChem] N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

(S)-5'-Deoxy-5'-(methylsulfinyl)adenosine

2-(6-Amino-9H-purin-9-yl)-5-(methanesulphinylmethyl)oxolane-3,4-diol

C11H15N5O4S (313.0845)


(S)-5-Deoxy-5-(methylsulfinyl)adenosine is found in mushrooms. (S)-5-Deoxy-5-(methylsulfinyl)adenosine is produced by Ganoderma lucidum (reishi). Production by Ganoderma lucidum (reishi). (R)-5-Deoxy-5-(methylsulfinyl)adenosine is found in mushrooms.

   

2-Methylthioadenosine

2-[6-amino-2-(methylsulfanyl)-9H-purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

C11H15N5O4S (313.0845)


   

Flubendazole

N-[6-(4-fluorobenzoyl)-1H-1,3-benzodiazol-2-yl]methoxycarboximidic acid

C16H12FN3O3 (313.0863)


P - Antiparasitic products, insecticides and repellents > P02 - Anthelmintics > P02C - Antinematodal agents > P02CA - Benzimidazole derivatives D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent Flubendazole is an anthelmintic drug based on altering microtubule structure, inhibition of tubulin polymerization and disruption of microtubule function. Flubendazole induces apoptosis in human colorectal cancer (CRC) by blocking the STAT3 signaling axis and activation of autophagy. Flubendazole induces P53 expression and reduced Cyclin B1 and p-cdc2 expression. Flubendazole is an antitumor agent. Flubendazole can be used for worm and intestinal parasites[1][2].

   

Salicylamide glucuronide

3,4,5-Trihydroxy-6-[2-(C-hydroxycarbonimidoyl)phenoxy]oxane-2-carboxylate

C13H15NO8 (313.0798)


   
   
   
   

Flubendazole

Flubendazole (Flutelmium)

C16H12FN3O3 (313.0863)


P - Antiparasitic products, insecticides and repellents > P02 - Anthelmintics > P02C - Antinematodal agents > P02CA - Benzimidazole derivatives D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent CONFIDENCE standard compound; EAWAG_UCHEM_ID 3659 CONFIDENCE standard compound; INTERNAL_ID 1163 CONFIDENCE standard compound; INTERNAL_ID 1063 Flubendazole is an anthelmintic drug based on altering microtubule structure, inhibition of tubulin polymerization and disruption of microtubule function. Flubendazole induces apoptosis in human colorectal cancer (CRC) by blocking the STAT3 signaling axis and activation of autophagy. Flubendazole induces P53 expression and reduced Cyclin B1 and p-cdc2 expression. Flubendazole is an antitumor agent. Flubendazole can be used for worm and intestinal parasites[1][2].

   
   

4-Amino-benzoyl-glucuronid|4-Amino-benzoylglucuronid|<1-(4-Amino-benzoyl)-glucosid>-uronsaeure

4-Amino-benzoyl-glucuronid|4-Amino-benzoylglucuronid|<1-(4-Amino-benzoyl)-glucosid>-uronsaeure

C13H15NO8 (313.0798)


   

O1-(2-carbamoyl-phenyl)-beta-D-glucopyranuronic acid|O1-(2-Carbamoyl-phenyl)-beta-D-glucopyranuronsaeure|Salicylamide glucuronide

O1-(2-carbamoyl-phenyl)-beta-D-glucopyranuronic acid|O1-(2-Carbamoyl-phenyl)-beta-D-glucopyranuronsaeure|Salicylamide glucuronide

C13H15NO8 (313.0798)


   

4-O-beta-D-glucopyranosyl-benzoxazolin-2(3H)-one

4-O-beta-D-glucopyranosyl-benzoxazolin-2(3H)-one

C13H15NO8 (313.0798)


   

O1-(3-carbamoyl-phenyl)-beta-D-glucopyranuronic acid|O1-(3-Carbamoyl-phenyl)-beta-D-glucopyranuronsaeure

O1-(3-carbamoyl-phenyl)-beta-D-glucopyranuronic acid|O1-(3-Carbamoyl-phenyl)-beta-D-glucopyranuronsaeure

C13H15NO8 (313.0798)


   
   

6-beta-D-glucopyranosyloxybenzoxazolin-2(3H)-one

6-beta-D-glucopyranosyloxybenzoxazolin-2(3H)-one

C13H15NO8 (313.0798)


   

O1-(4-carbamoyl-phenyl)-beta-D-glucopyranuronic acid|O1-(4-Carbamoyl-phenyl)-beta-D-glucopyranuronsaeure

O1-(4-carbamoyl-phenyl)-beta-D-glucopyranuronic acid|O1-(4-Carbamoyl-phenyl)-beta-D-glucopyranuronsaeure

C13H15NO8 (313.0798)


   

5-beta-D-glucopyranosyloxybenzoxazolin-2(3H)-one

5-beta-D-glucopyranosyloxybenzoxazolin-2(3H)-one

C13H15NO8 (313.0798)


   
   

flunitrazepam

flunitrazepam

C16H12FN3O3 (313.0863)


N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent CONFIDENCE standard compound; EAWAG_UCHEM_ID 3681 CONFIDENCE standard compound; INTERNAL_ID 1595

   

2-Methylthioadenosine; LC-tDDA; CE10

2-Methylthioadenosine; LC-tDDA; CE10

C11H15N5O4S (313.0845)


   

2-Methylthioadenosine; LC-tDDA; CE20

2-Methylthioadenosine; LC-tDDA; CE20

C11H15N5O4S (313.0845)


   

2-Methylthioadenosine; LC-tDDA; CE30

2-Methylthioadenosine; LC-tDDA; CE30

C11H15N5O4S (313.0845)


   

2-Methylthioadenosine; LC-tDDA; CE40

2-Methylthioadenosine; LC-tDDA; CE40

C11H15N5O4S (313.0845)


   

2-Methylthioadenosine; AIF; 0eV; CorrDec

2-Methylthioadenosine; AIF; 0eV; CorrDec

C11H15N5O4S (313.0845)


   

2-Methylthioadenosine; AIF; 30eV; CorrDec

2-Methylthioadenosine; AIF; 30eV; CorrDec

C11H15N5O4S (313.0845)


   

2-Methylthioadenosine; AIF; 10eV; CorrDec

2-Methylthioadenosine; AIF; 10eV; CorrDec

C11H15N5O4S (313.0845)


   

2-Methylthioadenosine; AIF; 0eV; MS2Dec

2-Methylthioadenosine; AIF; 0eV; MS2Dec

C11H15N5O4S (313.0845)


   

2-Methylthioadenosine; AIF; 10eV; MS2Dec

2-Methylthioadenosine; AIF; 10eV; MS2Dec

C11H15N5O4S (313.0845)


   

2-Methylthioadenosine; AIF; 30eV; MS2Dec

2-Methylthioadenosine; AIF; 30eV; MS2Dec

C11H15N5O4S (313.0845)


   

PI3-Kinase &alpha

3-[4-(4-morpholinyl)thieno[3,2-d]pyrimidin-2-yl-phenol

C16H15N3O2S (313.0885)


   

5'-Deoxy-5'-(methylsulfinyl)adenosine, 9CI

2-(6-amino-9H-purin-9-yl)-5-(methanesulfinylmethyl)oxolane-3,4-diol

C11H15N5O4S (313.0845)


   
   

3,5-DI(BENZO(D)OXAZOL-2-YL)PYRIDINE

3,5-DI(BENZO(D)OXAZOL-2-YL)PYRIDINE

C19H11N3O2 (313.0851)


   
   

5-[(4-METHOXYPHENOXY)METHYL]-4-PHENYL-4H-1,2,4-TRIAZOLE-3-THIOL

5-[(4-METHOXYPHENOXY)METHYL]-4-PHENYL-4H-1,2,4-TRIAZOLE-3-THIOL

C16H15N3O2S (313.0885)


   

3-[[1-(2,4-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL]AMINO]-1-PROPANOL

3-[[1-(2,4-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL]AMINO]-1-PROPANOL

C14H17Cl2N3O (313.0749)


   

3-(CHLOROPHENYLMETHYL)-1H-INDOLE-2-CARBOXYLIC ACID ETHYL ESTER

3-(CHLOROPHENYLMETHYL)-1H-INDOLE-2-CARBOXYLIC ACID ETHYL ESTER

C18H16ClNO2 (313.087)


   

(2-Methyl-4-phenylquinolin-3-yl)acetic acid hydrochloride

(2-Methyl-4-phenylquinolin-3-yl)acetic acid hydrochloride

C18H16ClNO2 (313.087)


   

1-Naphthalenesulfonicacid, 8-[(4-methylphenyl)amino]-

1-Naphthalenesulfonicacid, 8-[(4-methylphenyl)amino]-

C17H15NO3S (313.0773)


   

2-(Fluoroacetyl)-3-(2-methylphenyl)-6-nitroquinazolin-4(3H)-one

2-(Fluoroacetyl)-3-(2-methylphenyl)-6-nitroquinazolin-4(3H)-one

C16H12FN3O3 (313.0863)


   

3-[1-[(3,5-difluorophenyl)methyl]indol-3-yl]prop-2-enoic acid

3-[1-[(3,5-difluorophenyl)methyl]indol-3-yl]prop-2-enoic acid

C18H13F2NO2 (313.0914)


   

2-Methyl-5-{3-[4-(methylsulfonyl)phenyl]-2-furyl}pyridine

2-Methyl-5-{3-[4-(methylsulfonyl)phenyl]-2-furyl}pyridine

C17H15NO3S (313.0773)


   

2,6-BIS(BENZO[D]OXAZOL-2-YL)PYRIDINE

2,6-BIS(BENZO[D]OXAZOL-2-YL)PYRIDINE

C19H11N3O2 (313.0851)


   

Methyl 4,5-Di(1-imidazolyl)-2-nitrobenzoate

Methyl 4,5-Di(1-imidazolyl)-2-nitrobenzoate

C14H11N5O4 (313.0811)


   

2-(1-OXOPROPYL)-1-(PHENYLSULFONYL)-1H-INDOLE

2-(1-OXOPROPYL)-1-(PHENYLSULFONYL)-1H-INDOLE

C17H15NO3S (313.0773)


   
   

Methylthioadenosine sulfoxide

Methylthioadenosine sulfoxide

C11H15N5O4S (313.0845)


   

1-(3,4-Dimethylphenyl)-3-(2-pyrimidinylthio)pyrrolidine-2,5-dione

1-(3,4-Dimethylphenyl)-3-(2-pyrimidinylthio)pyrrolidine-2,5-dione

C16H15N3O2S (313.0885)


   
   
   

N,N,1-triethyl-2-sulfanyl-1H-1,3-benzodiazole-5-sulfonamide

N,N,1-triethyl-2-sulfanyl-1H-1,3-benzodiazole-5-sulfonamide

C13H19N3O2S2 (313.0919)


   
   

2-Methylthioadenosine

2-Methylthioadenosine

C11H15N5O4S (313.0845)


   

6-(Hydroxyethyldithio)-8-(aminomethylthio)octanoic acid

6-(Hydroxyethyldithio)-8-(aminomethylthio)octanoic acid

C11H23NO3S3 (313.084)


   

6-(2-carbamoylphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(2-carbamoylphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H15NO8 (313.0798)


   

3-(4-Morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl)phenol

3-(4-Morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl)phenol

C16H15N3O2S (313.0885)


   

N-[[[(2-methylphenyl)-oxomethyl]hydrazo]-sulfanylidenemethyl]benzamide

N-[[[(2-methylphenyl)-oxomethyl]hydrazo]-sulfanylidenemethyl]benzamide

C16H15N3O2S (313.0885)


   

2-methyl-N-[(5-nitro-2-furanyl)methylideneamino]-3-imidazo[1,2-a]pyridinecarboxamide

2-methyl-N-[(5-nitro-2-furanyl)methylideneamino]-3-imidazo[1,2-a]pyridinecarboxamide

C14H11N5O4 (313.0811)


   

1-(4-Methylphenyl)sulfonyl-4-phenyl-3-pyrazolamine

1-(4-Methylphenyl)sulfonyl-4-phenyl-3-pyrazolamine

C16H15N3O2S (313.0885)


   

N-(4-aminobutyl)-5-chloronaphthalene-2-sulfonamide(1+)

N-(4-aminobutyl)-5-chloronaphthalene-2-sulfonamide(1+)

C14H18ClN2O2S+ (313.0777)


   

3-[(6-Chloro-2-phenyl-1-benzopyran-4-ylidene)amino]-1-propanol

3-[(6-Chloro-2-phenyl-1-benzopyran-4-ylidene)amino]-1-propanol

C18H16ClNO2 (313.087)


   

[(2S)-2-[(2R)-2-[[(2R)-2-azaniumylpropanoyl]amino]propanoyl]oxy-3-hydroxypropyl] phosphate

[(2S)-2-[(2R)-2-[[(2R)-2-azaniumylpropanoyl]amino]propanoyl]oxy-3-hydroxypropyl] phosphate

C9H18N2O8P- (313.0801)


   

Lnape 2:0/N-3:0

Lnape 2:0/N-3:0

C10H20NO8P (313.0926)


   

Lnape 3:0/N-2:0

Lnape 3:0/N-2:0

C10H20NO8P (313.0926)


   

[1-Acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] propanoate

[1-Acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] propanoate

C10H20NO8P (313.0926)


   

(S)-5-Deoxy-5-(methylsulfinyl)adenosine

(S)-5-Deoxy-5-(methylsulfinyl)adenosine

C11H15N5O4S (313.0845)


   

5-Deoxy-5-(methylsulfinyl)adenosine

5-Deoxy-5-(methylsulfinyl)adenosine

C11H15N5O4S (313.0845)


A member of the class of adenosines obtained by replacement of the 5-hydroxy group of adenosine by a methylsulfinyl group.

   
   

PNB-001

PNB-001

C18H16ClNO2 (313.087)


PNB-001 is an orally active CCK2 selective ligand and antagonist. PNB-001 has anti-inflammatory and analgesic activities[1].

   

(2r,3r,4s,5s)-2-(6-aminopurin-9-yl)-5-(methanesulfinylmethyl)oxolane-3,4-diol

(2r,3r,4s,5s)-2-(6-aminopurin-9-yl)-5-(methanesulfinylmethyl)oxolane-3,4-diol

C11H15N5O4S (313.0845)


   

2-[(2-hydroxy-1,3-benzoxazol-6-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[(2-hydroxy-1,3-benzoxazol-6-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C13H15NO8 (313.0798)


   

2-acetyl-n-[2-(1h-indol-3-yl)ethyl]-1,3-thiazole-4-carboximidic acid

2-acetyl-n-[2-(1h-indol-3-yl)ethyl]-1,3-thiazole-4-carboximidic acid

C16H15N3O2S (313.0885)


   

(2s,3r,4s,5s,6r)-2-[(2-hydroxy-1,3-benzoxazol-6-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-[(2-hydroxy-1,3-benzoxazol-6-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C13H15NO8 (313.0798)


   

5,4'-dihydroxyl-6,7-dimethoxyl-8-c-[β-d-xylo-copyranosyl-(1→2)]-β-d-glucopyranosylflavone

NA

C10H17ClFN3O5 (313.0841)


{"Ingredient_id": "HBIN011052","Ingredient_name": "5,4'-dihydroxyl-6,7-dimethoxyl-8-c-[\u03b2-d-xylo-copyranosyl-(1\u21922)]-\u03b2-d-glucopyranosylflavone","Alias": "NA","Ingredient_formula": "C10H17ClFN3O5","Ingredient_Smile": "CC(C(=O)O)NC(=O)C(CCC(C(C(=O)O)N)(F)Cl)N","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5948","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

2-[(2-hydroxy-1,3-benzoxazol-5-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[(2-hydroxy-1,3-benzoxazol-5-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C13H15NO8 (313.0798)


   

(2s)-2-{[hydroxy(4-hydroxy-3,5-dimethoxyphenyl)methylidene]amino}butanedioic acid

(2s)-2-{[hydroxy(4-hydroxy-3,5-dimethoxyphenyl)methylidene]amino}butanedioic acid

C13H15NO8 (313.0798)


   

5-methyl-5,10,20-triazapentacyclo[11.7.1.0²,⁷.0⁹,²¹.0¹⁴,¹⁹]henicosa-1(20),2(7),3,9,11,13(21),14(19),15,17-nonaene-6,8-dione

5-methyl-5,10,20-triazapentacyclo[11.7.1.0²,⁷.0⁹,²¹.0¹⁴,¹⁹]henicosa-1(20),2(7),3,9,11,13(21),14(19),15,17-nonaene-6,8-dione

C19H11N3O2 (313.0851)


   

(2s,3r,4s,5s,6r)-2-[(2-hydroxy-1,3-benzoxazol-5-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-[(2-hydroxy-1,3-benzoxazol-5-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C13H15NO8 (313.0798)


   

(2r,3r,4s,5s)-2-(6-aminopurin-9-yl)-5-[(s)-methanesulfinylmethyl]oxolane-3,4-diol

(2r,3r,4s,5s)-2-(6-aminopurin-9-yl)-5-[(s)-methanesulfinylmethyl]oxolane-3,4-diol

C11H15N5O4S (313.0845)


   

5-methyl-5,10,20-triazapentacyclo[11.7.1.0²,⁷.0⁹,²¹.0¹⁴,¹⁹]henicosa-1(20),2,6,9,11,13(21),14(19),15,17-nonaene-4,8-dione

5-methyl-5,10,20-triazapentacyclo[11.7.1.0²,⁷.0⁹,²¹.0¹⁴,¹⁹]henicosa-1(20),2,6,9,11,13(21),14(19),15,17-nonaene-4,8-dione

C19H11N3O2 (313.0851)